Employees Provident Fund Board Purchases New Position in Cigna Group $CI

Employees Provident Fund Board bought a new position in shares of Cigna Group (NYSE:CIFree Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 76,000 shares of the health services provider’s stock, valued at approximately $20,917,000.

Other institutional investors also recently bought and sold shares of the company. Reflection Asset Management purchased a new stake in shares of Cigna Group during the fourth quarter worth $70,000. CFO Capital Management LLC purchased a new position in Cigna Group during the fourth quarter worth about $243,000. Kera Capital Partners Inc. raised its position in Cigna Group by 48.3% in the fourth quarter. Kera Capital Partners Inc. now owns 1,431 shares of the health services provider’s stock valued at $392,000 after purchasing an additional 466 shares during the period. MV Capital Management Inc. purchased a new stake in Cigna Group during the fourth quarter worth about $178,000. Finally, Cambient Family Office LLC acquired a new stake in shares of Cigna Group in the fourth quarter valued at $1,109,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on CI shares. Wolfe Research reaffirmed an “outperform” rating and set a $315.00 price objective on shares of Cigna Group in a research report on Tuesday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cigna Group in a report on Monday, June 1st. Raymond James Financial set a $340.00 price target on Cigna Group in a report on Friday, May 1st. Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday. Finally, The Goldman Sachs Group lifted their price objective on Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a research report on Monday, May 4th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $338.30.

Read Our Latest Analysis on CI

Cigna Group Stock Up 0.1%

Shares of Cigna Group stock opened at $279.63 on Friday. Cigna Group has a 1-year low of $239.51 and a 1-year high of $338.89. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. The company has a market capitalization of $73.97 billion, a PE ratio of 11.85, a P/E/G ratio of 1.08 and a beta of 0.28. The business has a 50-day moving average of $283.79 and a 200-day moving average of $278.33.

Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.60 by $0.19. The firm had revenue of $68.52 billion for the quarter, compared to analysts’ expectations of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm’s quarterly revenue was up 4.6% on a year-over-year basis. During the same period in the prior year, the company posted $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, equities analysts forecast that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th were issued a dividend of $1.56 per share. The ex-dividend date of this dividend was Thursday, June 4th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio is 26.45%.

Insider Activity

In other Cigna Group news, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the transaction, the chief executive officer owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the transaction, the chief accounting officer owned 2,368 shares in the company, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is currently owned by corporate insiders.

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Read More

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.